President’s FY 25 Funding Request for FDA - The Facts, The Alliance Response, The Budget Documents
This week’s Analysis and Commentary is entitled Q&A About FDA Funding for FY 24 and FY 25.
President’s FY 25 Funding Request for FDA–The Facts. The President’s FY 25 funding request for FDA is for $3.682 billion in budget authority (taxpayer) funding. This is an increase of $168 million, not quite 5% over the FY 2024 appropriated amount.
Almost $115 million of the proposed funding request would be for mandated salary increases.
Apart from that, the program elements of the budget request call for:
$15 million increase to strengthen and modernize FDA’s capacity to protect and promote a safe, nutritious U.S. food supply.
$13.3 million to hire additional inspectors and implement other approaches to address product shortages and supply chain disruption (food and medical products), including $1 million for support of foreign offices.
$8 million for modernization and reform of cosmetics regulation.
$10.3 million to improve FDA’s enterprise data management and business processes.
We have also linked a table showing 1/ how the requested FY 25 monies would be distributed across the FDA’s Centers and offices and 2/ compared to the final FY 24 appropriations levels enacted last week. Some additional analysis is included in materials sent out by the Alliance on March 13 (here).
President’s FY 25 Funding Request for FDA—The Alliance Response. Following Monday’s release of the President’s FY 25 Budget Request, the Alliance for a Stronger FDA issued the following statement to the media, stakeholders, and the public.
------------------
The Alliance for a Stronger FDA supports the President’s request for an increase in FDA’s FY25 budget authority (taxpayer) funding. The request is for an increase of $168 million, not quite 5% over the FY 2024 appropriated amount.
However, $115 million of the increase would be for mandated salary increases, leaving very little to cover growing demands on the agency.
We will be asking Congress for additional FY 25 FDA funding so that the agency can make essential investments in:
Modernizing its information technology and data management infrastructure to support better-informed decisionmaking, and
Programs that will keep the agency on pace with increasingly-sophisticated technologies and societal needs.
------------------
President’s FY 25 Funding Request for FDA—The Budget Documents. In order of increasing detail, the relevant budget documents are:
FY-2025-budget-in-brief.pdf (hhs.gov)(FDA beginning page 24 of the pdf/page 18 of the text), and
FDA Fiscal Year 2025 Justification of Estimates for Appropriations Committees
Updated House and Senate Member FY 2025 Appropriation Request Information. House and Senate Members continue to release their individual office deadlines for the submission of FY 2025 appropriation requests. The Alliance will submit its FY 2025 recommendations to these offices.
Attached here (House) and here (Senate) are updated lists of those deadlines with links to the individual request forms. We will continue to update these lists as additional information becomes available.
We urge Alliance members to also respond to these offices with the message: FDA is a funding priority because of its role in protecting public health and advancing food safety and innovative medical products.
If you have any questions, please contact Roger Szemraj.
Did You Catch Friday’s Alliance Webinars? The summaries and transcripts are now available for both Jim Jones, Deputy Commissioner for Human Foods, and Dr. Nicole Verdun, Director of CBER Office of Therapeutic Products.
Jim Jones, Deputy Commissioner for Human Foods, summary is here and transcript is here. Media coverage is here, here, here, here, here, and here.
Dr. Nicole Verdun, Director of CBER Office of Therapeutic Products, summary is here and transcript will be available early next week.
Introducing the Alliance’s Annual Budget Series. After the release of the President’s Budget Request, the Alliance schedules its annual budget webinar series. featuring center directors and other FDA senior leaders discussing their portion of the President’s request. There are five events scheduled so far, register below:
CVM Director Tracey Forfa on Tuesday, April 2 at 2 pm. Register here.
Human Foods Program (HFP) Deputy Commissioner Jim Jones on Friday, April 5 at 11 am. Register here.
CBER Director Dr. Peter Marks on Tuesday, April 23 at 2 pm. Register here.
CDER Director Dr, Patrizia Cavazzoni on Monday, May 6 at 2:30 pm. Register here.
CDRH Director Dr. Jeff Shuren on Tuesday, May 14 at 2 pm. Register here.
We expect to add two more webinars, one on the Office of Regulatory Affairs and the other on the Office of the Commissioner.